Removal of cannabis from Schedule I of the Controlled Substances Act

This article is about cannabis rescheduling in the United States. For other uses, see Cannabis rescheduling (disambiguation).

Part of a series on
Cannabis
Cannabis
Chemistry
  • Semi-synthetic cannabinoids
Pharmacology
Consumption
Economics
Effects
Forms
Law
Variants
  • Genus
  • Species
Related

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, the U.S. Department of Justice initiated 2024 rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act. The majority of 2024 public comments supported descheduling, decriminalizing, or legalizing marijuana at the federal level.[1]

  1. ^ DeAngelo, Andrew (August 12, 2024). "Cannabis Rescheduling: Record 43,000 Public Comments Submitted To The DEA". Forbes. Retrieved August 13, 2024.